Novel recombinant human thrombopoietin analogues having enhanced in vivo activity.

被引：0
|
作者：
Lim, SW [1 ]
Park, SK [1 ]
Park, J [1 ]
Ahn, HK [1 ]
Ju, SM [1 ]
Chang, WIK [1 ]
Chung, JY [1 ]
Koh, YW [1 ]
Park, SK [1 ]
机构：
[1] Daewoong Pharm Co Ltd, R&D Ctr, Kyunggi Do, South Korea
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3956
引用
收藏
页码：175B / 175B
页数：1
相关论文
共 50 条
  • [31] AVE5026: A novel, extractive heparinoid with enriched anti-Xa activity and enhanced Antithrombotic activity.
    Hoppensteadt, Debra
    Cunanan, Josephine
    Geniaux, Eric
    Lorenz, Martin
    Viskov, Christian
    Ythier-Moury, Pascal
    Brin, Jean-Francois
    Jeske, Walter
    BLOOD, 2007, 110 (11) : 557A - 557A
  • [32] Effect of sodium butyrate on the production, heterogeneity and biological activity of human thrombopoietin by recombinant Chinese hamster ovary cells
    Sung, YH
    Song, YJ
    Lim, SW
    Chung, JY
    Lee, GM
    JOURNAL OF BIOTECHNOLOGY, 2004, 112 (03) : 323 - 335
  • [33] Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity In Vitro and Tissue Selectivity In Vivo
    Dart, D. Alwyn
    Kandil, Sahar
    Tommasini-Ghelfi, Serena
    de Almeida, Gilberto Serrano
    Bevan, Charlotte L.
    Jiang, Wenguo
    Westwell, Andrew D.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (09) : 1846 - 1858
  • [34] Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity
    Gill, Avinash
    Scanlon, Thomas C.
    Osipovitch, Daniel C.
    Madden, Dean R.
    Griswold, Karl E.
    PLOS ONE, 2011, 6 (03):
  • [35] Novel 3-deoxy-3-descladinosyl-6-O-methyl erythromycin A analogues. Synthesis and in vitro activity.
    Elliott, RL
    Pireh, D
    Nilius, AM
    Johnson, PM
    Flamm, RK
    Chu, DTW
    Plattner, JJ
    Or, YS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (05) : 641 - 646
  • [36] Discovery of NVP-LAQ824, a novel histone deacetylase inhibitor with in vitro and in vivo antitumor activity.
    Remiszewski, SW
    Sambucetti, LC
    Atadja, P
    Bair, KW
    Bontempo, J
    Cesarz, D
    Chandramouli, N
    Chen, R
    Dean, K
    Diamantidis, G
    Green, MA
    Howell, KL
    Kashi, R
    Kwon, P
    Lassota, P
    Mou, Y
    Nemzek, R
    Perez, LB
    Sorensen, E
    Taplin, F
    Trogani, N
    Versace, R
    Walker, H
    Weltchek-Engler, S
    Wood, AW
    Wu, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U46 - U46
  • [37] R123942, a novel thiadiazole pyridazine with potent in vitro and in vivo anti-angiogenic activity.
    Tuman, R
    Herb, M
    Thomas, S
    Tominovich, R
    Wallace, N
    Valletta, L
    Bongartz, JP
    Smets, G
    Stokbroekx, R
    Van Ginckel, R
    Wouters, W
    CLINICAL CANCER RESEARCH, 2000, 6 : 4523S - 4523S
  • [38] Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A
    Nandigama, RK
    Edmondson, DE
    BIOCHEMISTRY, 2000, 39 (49) : 15258 - 15265
  • [39] Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo
    Guilford, WJ
    Bauman, JG
    Skuballa, W
    Bauer, S
    Wei, GP
    Davey, D
    Schaefer, C
    Mallari, C
    Terkelsen, J
    Tseng, JL
    Shen, J
    Subramanyam, B
    Schottelius, AJ
    Parkinson, JF
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (08) : 2157 - 2165
  • [40] Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity
    Habens, F
    Srinivasan, N
    Oakley, F
    Mann, DA
    Ganesan, A
    Packham, G
    APOPTOSIS, 2005, 10 (03) : 481 - 491
12345